Pritumumab
Modify Date: 2024-01-03 16:56:07
Pritumumab structure
|
Common Name | Pritumumab | ||
|---|---|---|---|---|
| CAS Number | 499212-74-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PritumumabPritumumab is a natural human IgG1kappa mAb originally isolated from a regional draining lymph node of a patient with cervical carcinoma. Pritumumab recognizes vimentin expressing on the cell surface of the malignant tumor. Pritumumab can be used for glioblastoma research[1][2]. |
| Name | Pritumumab |
|---|
| Description | Pritumumab is a natural human IgG1kappa mAb originally isolated from a regional draining lymph node of a patient with cervical carcinoma. Pritumumab recognizes vimentin expressing on the cell surface of the malignant tumor. Pritumumab can be used for glioblastoma research[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Pritumumab 在裸鼠中有效阻止肿瘤生长，但在SCID小鼠中无效[1]。 Pritumumab 只有在完整的细胞介导免疫存在的情况下，才能限制体内异种移植胶质瘤肿瘤的生长[1]。 |
| References |
| No Any Chemical & Physical Properties |